Skip to main content
. 2022 Sep 29;50(9):03000605221126874. doi: 10.1177/03000605221126874

Figure 1.

Figure 1.

FGL-1 expression in laryngeal cancer. The expression of FGL-1 in plasma samples of laryngeal cancer patients divided by different clinical characteristics including diagnosis, clinical stage, pathological grade, primary tumor site, lymphatic metastasis, tumor size, smoking history, and drinking history (a) and *p < 0.05, **p < 0.01; two-tailed Student’s t-test. Immunohistochemical stanning of FGL-1 in laryngeal cancer tissues and vocal cord polyp tissues (control) (b). Scale bars, 100 µm.